menu
    • menu

    Company profile for INFEX Therapeutics

    NEW Drugs in Dev: 2
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We acquire, develop and license innovative drugs to treat pandemic infections. We have expanded to develop a broader portfolio of new therapies to meet the rising burden of critical priority infectious disease. Based at Alderley Park in the North West of England, our work addresses unmet patient needs and will bring new portfolio of drugs into clinical trials to treat patients suffering from life-threatening infections.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    INFEX Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Mereside, Alderley Park, Alderley Edge, North West SK10 4TG, GB
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.infextx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/infex-tx/?originalSubdomain=uk
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Infex RESP-X Shows Positive Phase IIa Results in Bronchiectasis
    Infex RESP-X Shows Positive Phase IIa Results in Bronchiectasis

    21 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/21/3299012/0/en/infex-therapeutics-announces-positive-phase-iia-results-for-resp-x-in-non-cystic-fibrosis-bronchiectasis-patients-colonised-with-pseudomonas-aeruginosa.html

    GLOBENEWSWIRE
    21 May 2026
    Share Share
    Infex Therapeutics Raises £4.3M for Anti-Infective Pipeline
    Infex Therapeutics Raises £4.3M for Anti-Infective Pipeline

    12 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/12/3292488/0/en/infex-therapeutics-secures-4-3-million-funding-to-advance-anti-infective-pipeline-targeting-drug-resistant-infections.html

    GLOBENEWSWIRE
    12 May 2026
    Share Share
    Infex Secures £4.3M Funding to Advance Anti-infective pipeline
    Infex Secures £4.3M Funding to Advance Anti-infective pipeline

    12 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/12/3292488/0/en/infex-therapeutics-secures-4-3-million-funding-to-advance-anti-infective-pipeline-targeting-drug-resistant-infections.html

    GLOBENEWSWIRE
    12 May 2026
    Share Share
    Report Shows Iicon Has Helped Boost Regional R&D Spend to £1 B
    Report Shows Iicon Has Helped Boost Regional R&D Spend to £1 B

    06 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-06/new-report-shows-iicon-has-helped-boost-regional-rd-spend-to-over-1-billion

    PHARMIWEB
    06 Nov 2025
    Share Share
    Venus Remedies In-Licenses MET-X From Infex For India
    Venus Remedies In-Licenses MET-X From Infex For India

    27 Feb 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/venus-remedies-secures-in-licensing-rights-from-infex-therapeutics-to-develop-and-commercialize-met-x-in-india-16834

    INDPHARMAPOST
    27 Feb 2025
    Share Share
    Positive study results for Infex’s RESP-X
    Positive study results for Infex’s RESP-X

    06 Apr 2023

    // PHARMATIMES

    https://www.pharmatimes.com/news/positive_study_results_for_infexs_resp-x_1490456

    PHARMATIMES
    06 Apr 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search